7TM Pharma

company

About

7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, asthma, and more.

Details

Last Funding Type
Series A
Last Funding Money Raised
$15M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2000
Operating Status
Active

7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, gastrointestinal, metabolic, asthma, and vascular diseases. The company offers seven transmembrane-spanning receptors, including TM38837, a small molecule CB1 receptor antagonist; TM30339, a NPY Y4 selective agonist that is used within gastrointestinal disorders, and short bowel syndrome; and CRTH2 antagonist, an oral drug for inflammatory or respiratory diseases.

7TM Pharma was founded in 2000 and is based in Lyngby, Hovedstaden.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$37M €25M
7TM Pharma has raised a total of $37M €25M in funding over 2 rounds. Their latest funding was raised on Jun 12, 2007 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 12, 2007 Series D $22M 1 Detail
Mar 31, 2006 Series C €19M 1 Detail
Oct 28, 2004 Series B €6M 1 Detail
Sep 27, 2001 Series A $15M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
7TM Pharma is funded by 2 investors. Dansk Innovation and LODH Immunology Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Dansk Innovation Series D
LODH Immunology Fund Series A